Overview Fundamentals API Earnings EOD API Sample Code Pricing

CROSSJECT SA EO -10 (74C F) stock market data APIs

€1.68 0(0%) as of July 26, 2024
Price chart is built with Anychart

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, a needle-free device for patient-side management disorders self-injectables. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. The company was founded in 2001 and is based in Dijon, France.

CROSSJECT SA EO -10 Financial Data Overview

1.68
1.68
-
1.68
1.68
1.43-5.76
75 030 K
41 127 K
3 872 K
0.956
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '74C',
Type: 'Common Stock',
Name: 'CROSSJECT SA EO -10',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'FR0011716265',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Medical Instruments & Supplies',
}

CROSSJECT SA EO -10 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 872 K
  • EBITDA -10 752 000
  • Earnings Per Share -0.36
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get CROSSJECT SA EO -10 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get CROSSJECT SA EO -10 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com